S. Welkos

发表

Identification and characterization of a trans-activator involved in the regulation of encapsulation by Bacillus anthracis.

N. Vietri, R. Marrero, T. Hoover, 1995, Gene.

The capsule of Bacillus anthracis, a review

J. Ezzell, S. Welkos, 1999, Journal of applied microbiology.

Interrogation of the Burkholderia pseudomallei Genome to Address Differential Virulence among Isolates

S. Kern, S. Welkos, J. Challacombe, 2014, PloS one.

Incorporating germination‐induction into decontamination strategies for bacterial spores

S. Welkos, C. Cote, L. Kohler, 2018, Journal of applied microbiology.

Animal Models for the Pathogenesis, Treatment, and Prevention of Infection by Bacillus anthracis.

S. Welkos, J. Bozue, C. Cote, 2015, Microbiology spectrum.

Differences in susceptibility of inbred mice to Bacillus anthracis

S. Welkos, T. Keener, P. Gibbs, 1986, Infection and immunity.

Effects of altering the germination potential of Bacillus anthracis spores by exogenous means in a mouse model.

S. Welkos, J. Bozue, C. Cote, 2009, Journal of medical microbiology.

Characterization of a Bacillus anthracis spore coat-surface protein that influences coat-surface morphology.

Peter T. McKenney, S. Welkos, P. Eichenberger, 2008, FEMS microbiology letters.

Roles of macrophages and neutrophils in the early response to Bacillus anthracis spores in a mouse model of infection , Infection and Immunity

S. Welkos, C. Cote, N. Rooijen, 2006 .

The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores.

S. Welkos, N. Van Rooijen, C. Cote, 2004, Microbial pathogenesis.

In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody.

S. Welkos, A. Friedlander, S. Little, 2002, Journal of medical microbiology.

Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys

S. Welkos, B. Ivins, P. Worsham, 1996 .

Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge

S. Welkos, A. Friedlander, G. P. Andrews, 1996, Infection and immunity.

Cutting Edge: Resistance to Bacillus anthracis Infection Mediated by a Lethal Toxin Sensitive Allele of Nalp1b/Nlrp1b

S. Welkos, J. Bozue, C. Cote, 2009, The Journal of Immunology.

Phenotypic changes in spores and vegetative cells of Bacillus anthracis associated with BenK.

S. Welkos, J. Bozue, C. Cote, 2013, Microbial pathogenesis.

Application of carbohydrate microarray technology for the detection of Burkholderia pseudomallei, Bacillus anthracis and Francisella tularensis antibodies.

S. Welkos, D. DeShazer, S. Peacock, 2008, Carbohydrate research.

Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection.

S. Welkos, C. Cote, K. Bradley, 2008, Microbes and infection.

A Unique Set of the Burkholderia Collagen-Like Proteins Provides Insight into Pathogenesis, Genome Evolution and Niche Adaptation, and Infection Detection

R. Berisio, S. Welkos, J. Bozue, 2015, PloS one.

The Impact of Age and Sex on Mouse Models of Melioidosis

S. Welkos, C. Klimko, P. Worsham, 2020, Pathogens.

Importance of anaerobic bacteria in the cobalamin malabsorption of the experimental rat blind loop syndrome

S. Welkos, P. Toskes, H. Baer, 1981 .

Regulation of toxinogenesis in Corynebacterium diphtheriae. II. Genetic mapping of a tox regulatory mutation in bacteriophage beta

S. Welkos, R. Holmes, 1981, Journal of virology.

Advanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges

S. Welkos, M. K. Hart, R. House, 2011, Advances in preventive medicine.

A strategy to verify the absence of the pgm locus in Yersinia pestis strain candidates for select agent exemption.

S. Welkos, P. Worsham, A. Jenkins, 2009, Journal of microbiological methods.

Modified Caspase-3 Assay Indicates Correlation of Caspase-3 Activity with Immunity of Nonhuman Primates to Yersinia pestis Infection

S. Welkos, J. Adamovicz, S. Norris, 2008, Clinical and Vaccine Immunology.

Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice.

S. Welkos, A. Friedlander, G. W. Anderson, 1998, The American journal of tropical medicine and hygiene.

In Vitro Intracellular Trafficking of Virulence Antigen during Infection by Yersinia pestis

G. Ruthel, S. Welkos, H. Hines, 2009, PloS one.

Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.

Leonard A. Smith, S. Welkos, A. Hadjipanayis, 2006, Vaccine.

Antibiotic Treatment of Experimental Pneumonic Plague in Mice

J. Ezzell, S. Welkos, A. Friedlander, 1998, Antimicrobial Agents and Chemotherapy.

Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops).

S. Welkos, P. Worsham, A. Friedlander, 1996, Archives of pathology & laboratory medicine.

Protection Elicited by Attenuated Live Yersinia pestis Vaccine Strains against Lethal Infection with Virulent Y. pestis

Jennifer L. Dankmeyer, S. Welkos, C. Klimko, 2021, Vaccines.

Immunochemical studies of diphtherial toxin and related nontoxic mutant proteins.

S. Welkos, R. Holmes, S. Cryz, 1980, Infection and immunity.

Characterization of a screening test for diphtherial toxin antigen produced by individual plaques of corynebacteriophages

S. Welkos, R. Holmes, 1979, Journal of clinical microbiology.

Mu dI1(Ap lac) mutagenesis of Yersinia pestis plasmid pFra and identification of temperature-regulated loci associated with virulence.

S. Welkos, L. Lindler, N. Snellings, 2004, Plasmid.

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine.

S. Welkos, A. Friedlander, G. P. Andrews, 1998, Vaccine.

Analysis of the Yersinia pestis V Protein for the Presence of Linear Antibody Epitopes

S. Welkos, J. K. Pullen, A. Friedlander, 1998, Infection and Immunity.

Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid pX02 and chromosome in strain-dependent virulence.

N. Vietri, S. Welkos, P. Gibbs, 1993, Microbial pathogenesis.

Evaluation of two different vaccine platforms for immunization against melioidosis and glanders

Jennifer L. Dankmeyer, S. Welkos, D. DeShazer, 2022, Frontiers in Microbiology.

Development of In Vitro Correlate Assays of Immunity to Infection with Yersinia pestis

S. Welkos, J. Bashaw, J. Adamovicz, 2007, Clinical and Vaccine Immunology.

Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia 1 mallei strains isolated from infected mice

S. Welkos, C. Klimko, C. Cote, 2017 .

Dysregulation of TNF-α and IFN-γ expression is a common host immune response in a chronically infected mouse model of melioidosis when comparing multiple human strains of Burkholderia pseudomallei

Jennifer L. Dankmeyer, S. Welkos, P. Worsham, 2020, BMC Immunology.

Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice.

S. Welkos, A. Friedlander, K. Davis, 1997, Archives of pathology & laboratory medicine.

Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice

S. Welkos, C. Klimko, P. Worsham, 2016, Archives of Microbiology.

Identification of Salmonella with the O-1 bacteriophage.

S. Welkos, H. Baer, M. Schreiber, 1974, Applied microbiology.

Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis.

S. Welkos, P. Worsham, A. Friedlander, 1997, The American journal of tropical medicine and hygiene.

A modified broth-disk antibiotic susceptibility test forCampylobacter jejuni

S. Welkos, 1982, European Journal of Clinical Microbiology.

Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB/c mice.

Jennifer L. Dankmeyer, S. Welkos, P. Worsham, 2015, Microbial pathogenesis.

Animal Models for Melioidosis

S. Welkos, D. DeShazer, J. Bozue, 2017, Current Tropical Medicine Reports.

Combinations of early generation antibiotics and antimicrobial peptides are effective against a broad spectrum of bacterial biothreat agents.

S. Welkos, C. Klimko, C. Cote, 2020, Microbial pathogenesis.

Protective Efficacy of RecombinantYersinia Outer Proteins against Bubonic Plague Caused by Encapsulated and Nonencapsulated Yersinia pestis

S. Welkos, J. K. Pullen, A. Friedlander, 1999, Infection and Immunity.

Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis

S. Welkos, R. Titball, P. Worsham, 1996, Infection and immunity.

Cul-de-sac isolates from patients with endometritis-salpingitis-peritonitis and gonococcal endocervicitis.

S. Welkos, R. J. Thompson, H. Baer, 1976, American journal of obstetrics and gynecology.

V antigen ofYersinia pestisinhibits neutrophil chemotaxis

S. Welkos, A. Friedlander, D. McDowell, 1998 .

Efficacy of Treatment with the Antibiotic Novobiocin against Infection with Bacillus anthracis or Burkholderia pseudomallei

S. Welkos, D. DeShazer, C. Klimko, 2022, Antibiotics.

Determination of median lethal and infectious doses in animal model systems.

S. Welkos, A. O'Brien, 1994, Methods in enzymology.

The Use of Analgesics during Vaccination with a Live Attenuated Yersinia pestis Vaccine Alters the Resulting Immune Response in Mice

Jennifer L. Dankmeyer, S. Welkos, C. Klimko, 2019, Vaccines.

Immunization of Mice with Formalin-Inactivated Spores from Avirulent Bacillus cereus Strains Provides Significant Protection from Challenge with Bacillus anthracis Ames

S. Welkos, J. Bozue, C. Cote, 2012, Clinical and Vaccine Immunology.

Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.

S. Welkos, A. Friedlander, 1988, Microbial pathogenesis.

The impact of inducing germination of Bacillus anthracis and Bacillus thuringiensis spores on potential secondary decontamination strategies

S. Welkos, C. Klimko, J. Bozue, 2014, Journal of applied microbiology.

Clinical response of patients with gonococcal endocervicitis and endometritis-salpingitis-peritonitis to doxycycline.

S. Welkos, H. Baer, G. Monif, 1977, American journal of obstetrics and gynecology.

Allelic Variation on Murine Chromosome 11 Modifies Host Inflammatory Responses and Resistance to Bacillus anthracis

S. Welkos, A. Lusis, M. Mehrabian, 2011, PLoS pathogens.

D‐cycloserine or similar physiochemical compounds may be uniquely suited for use in Bacillus anthracis spore decontamination strategies

S. Welkos, C. Klimko, J. Bozue, 2013, Journal of applied microbiology.

Roles of Macrophages and Neutrophils in the Early Host Response to Bacillus anthracis Spores in a Mouse Model of Infection

S. Welkos, N. Van Rooijen, C. Cote, 2006, Infection and Immunity.

Localization and assembly of proteins comprising the outer structures of the Bacillus anthracis spore.

S. Welkos, A. Driks, J. Bozue, 2009, Microbiology.

EXPERIMENTAL GASTROENTERITIS IN NEWLY-HATCHED CHICKS INFECTED WITH C A M P Y L O B A C T E R JEJUNZ

S. Welkos, 2008 .

Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice.

S. Welkos, G. Nelson, R. Trotter, 1989, Microbial pathogenesis.

A DUF4148 family protein produced inside RAW264.7 cells is a critical Burkholderia pseudomallei virulence factor

S. Welkos, D. DeShazer, Udoka Okaro, 2020, Virulence.

Role of Purine Biosynthesis in Bacillus anthracis Pathogenesis and Virulence

S. Welkos, T. Merkel, J. Bozue, 2010, Infection and Immunity.

Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei.

Jennifer L. Dankmeyer, S. Kern, S. Welkos, 2021, Microbial pathogenesis.

Venezuelan Equine Encephalitis Virus-Vectored Vaccines Protect Mice against Anthrax Spore Challenge

S. Welkos, A. Hadjipanayis, John S. Lee, 2003, Infection and Immunity.

Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences

S. Kern, S. Welkos, G. Palacios, 2017, PloS one.

Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays

S. Kern, S. Welkos, C. Klimko, 2015, PloS one.

Importance of anaerobic bacteria in the cobalamin malabsorption of the experimental rat blind loop syndrome.

S. Welkos, P. Toskes, H. Baer, 1981, Gastroenterology.

Comparison of sampling methods to recover germinated Bacillus anthracis and Bacillus thuringiensis endospores from surface coupons

T. Mott, S. Welkos, C. Klimko, 2017, Journal of applied microbiology.

The Bacillus anthracis Exosporium: What's the Big "Hairy" Deal?

S. Welkos, J. Bozue, C. Cote, 2015, Microbiology spectrum.

Bacillus anthracis and Other Bacillus Species

S. Welkos, J. Bozue, C. Cote, 2015 .

Key aspects of the molecular and cellular basis of inhalational anthrax.

S. Welkos, J. Bozue, C. Cote, 2011, Microbes and infection.

The Interactions between Bacillus anthracis and Macrophages

S. Welkos, J. Bozue, C. Cote, 2010 .

Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization.

S. Welkos, J. Bozue, C. Cote, 2008, Microbiology.

Morphogenesis of the Bacillus anthracis Spore

S. Welkos, J. Maddock, A. Driks, 2006, Journal of bacteriology.

Bacillus anthracis: Agent of Bioterror and Disease

S. Welkos, J. Bozue, C. Cote, 2006 .

Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei

Jennifer L. Dankmeyer, S. Kern, S. Welkos, 2018, PloS one.

Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis.

S. Welkos, P. Worsham, A. Friedlander, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Regulation of toxinogenesis in Corynebacterium diphtheriae. I. Mutations in bacteriophage beta that alter the effects of iron on toxin production

S. Welkos, R. Holmes, 1981, Journal of virology.

Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis.

S. Welkos, S. Leppla, J. J. Schmidt, 1988, Gene.

Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants

S. Welkos, B. Ivins, G. Nelson, 1992, Infection and immunity.

Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals

S. Welkos, B. Ivins, J. Dalrymple, 1991, Infection and immunity.

The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

S. Welkos, A. Friedlander, S. Little, 2001, Microbiology.

Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice.

S. Welkos, A. Friedlander, 1988, Microbial pathogenesis.

Postexposure prophylaxis against experimental inhalation anthrax.

J. Ezzell, S. Welkos, B. Ivins, 1993, The Journal of infectious diseases.

Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis

S. Welkos, B. Ivins, 1986, Infection and immunity.

Detection of small intestine bacterial overgrowth by means of a 14C-D-xylose breath test.

S. Welkos, P. Toskes, C. King, 1979, Gastroenterology.

Comparison of the one-gramd-[14C]xylose breath test to the [14C]bile acid breath test in patients with small-intestine bacterial overgrowth

T. Guilarte, S. Welkos, P. Toskes, 2005, Digestive Diseases and Sciences.

Bacteriophage‐associated genes responsible for the widely divergent phenotypes of variants of Burkholderia pseudomallei strain MSHR5848

S. Welkos, D. DeShazer, P. Worsham, 2019, Journal of medical microbiology.

Transposon Tn916 mutagenesis in Bacillus anthracis

S. Welkos, B. Ivins, D. J. Leblanc, 1988, Infection and immunity.

A Standard Method To Inactivate Bacillus anthracis Spores to Sterility via Gamma Irradiation

Jerry W. Pfarr, Alena M Calm, Casey B. Bernhards, 2018, Applied and Environmental Microbiology.

Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen

S. Welkos, B. Ivins, S. Little, 1990, Infection and immunity.

Plasmid-associated virulence factors of non-toxigenic (pX01-) Bacillus anthracis.

S. Welkos, 1991, Microbial pathogenesis.

Recent advances in the development of an improved, human anthrax vaccine

S. Welkos, B. Ivins, 1988, European Journal of Epidemiology.

OF AN IMPROVED, HUMAN ANTHRAX VACCINE

S. Welkos, B. Ivins, 2016 .

Bacillus anthracis Spores of the bclA Mutant Exhibit Increased Adherence to Epithelial Cells, Fibroblasts, and Endothelial Cells but Not to Macrophages

S. Welkos, J. Bozue, C. Cote, 2007, Infection and Immunity.

Fully Virulent Bacillus anthracis Does Not Require the Immunodominant Protein BclA for Pathogenesis

S. Welkos, J. Bozue, C. Cote, 2006, Infection and Immunity.

The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.

P. R. Morrow, S. Welkos, Angray S. Kang, 2005, Microbial pathogenesis.

Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia.

S. Welkos, J. Bozue, C. Cote, 2012, Journal of medical microbiology.

Protective Efficacy and Safety of Live Anthrax Vaccines for Mice

S. Welkos, 1987 .

Experimental gastroenteritis in newly-hatched chicks infected with Campylobacter jejuni.

S. Welkos, 1984, Journal of medical microbiology.

CUL-DE-SAC ISOLATES FROM PATIENTS WITH ENDOMETRITIS-SALPINGI-TIS-PERITONITIS AND GONOCOCCAL ENDOCERVICITIS

R. J. Thompson, S. Welkos, H. Baer, 1977 .

Identification of Salmonella with the O-1 Bacteriophage

S. Welkos, H. Baer, M. Schreiber, 1974 .

Identification of Salmonella with the 0-1 Bacteriophage

S. Welkos, H. Baer, M. Schreiber, 2022 .

Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination

S. Welkos, C. Cote, 2015, Toxins.

Laser Scanning Confocal Microscopy Was Used to Validate the Presence of Burkholderia pseudomallei or B. mallei in Formalin-Fixed Paraffin Embedded Tissues

Jennifer L. Dankmeyer, S. Welkos, P. Worsham, 2020, Tropical medicine and infectious disease.

Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice

Jennifer L. Dankmeyer, S. Welkos, C. Klimko, 2017, PloS one.

Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague.

S. Welkos, A. Friedlander, M. Pitt, 2002, Vaccine.

Roles of the Bacillus anthracis Spore Protein ExsK in Exosporium Maturation and Germination

S. Welkos, A. Driks, J. Bozue, 2009, Journal of bacteriology.

Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain C092.

S. Welkos, A. Friedlander, K. Davis, 1997, Microbial pathogenesis.

Humanized θ-Defensins (Retrocyclins) Enhance Macrophage Performance and Protect Mice from Experimental Anthrax Infections

S. Welkos, R. Lehrer, J. Bozue, 2011, Antimicrobial Agents and Chemotherapy.

Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis.

S. Welkos, A. Friedlander, S. Weeks, 2002, Microbial pathogenesis.

V antigen of Yersinia pestis inhibits neutrophil chemotaxis.

S. Welkos, A. Friedlander, D. McDowell, 1998, Microbial pathogenesis.

Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis.

S. Welkos, P. Worsham, L. Pitt, 1995, Contributions to microbiology and immunology.

Construction of defined F1 negative mutants of virulent Yersinia pestis.

S. Welkos, P. Worsham, M. Stein, 1995, Contributions to microbiology and immunology.

The transformation frequency of plasmids into Bacillus anthracis is affected by adenine methylation.

R. Marrero, S. Welkos, 1995, Gene.

A microtiter fluorometric assay to detect the germination of Bacillus anthracis spores and the germination inhibitory effects of antibodies.

S. Welkos, C. Cote, P. Gibbs, 2004, Journal of microbiological methods.

Nalp 1 b / Nlrp 1 b Lethal Toxin Sensitive Allele of Infection Mediated by aanthracis BacillusCutting Edge : Resistance to

S. Welkos, J. Bozue, C. Cote, 2010 .

Toxin Sensitive Allele of Infection Mediated by a Lethal anthracis Bacillus Cutting Edge : Resistance to and

S. Welkos, J. Bozue, C. Cote, 2009 .

Delayed Toxicity Associated with Soluble Anthrax Toxin Receptor Decoy-Ig Fusion Protein Treatment

John A. Young, S. Welkos, C. Cote, 2012, PloS one.